Medgenics, Inc. (MDGN)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
5.10+0.14 (+2.82%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close4.96
Bid0.00 x
Ask5.48 x 200
Day's Range4.95 - 5.18
52wk Range3.09 - 7.57
1y Target EstN/A
Market Cap189.1M
P/E Ratio (ttm)-3.44
Avg Vol (3m)111,509
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • American City Business Journals9 days ago

    Main Line gene therapy company is trading exchanges

    Medgenics is switching stock exchanges. The Wayne, Pennsylvania, gene therapy company’s application to have its stock listed on the NASDAQ Global Market has been approved. MedGenics stock was previously traded on the NYSEMKT exchange, formerly known as the American Stock Exchange.

  • Marketwired11 days ago

    Medgenics, Inc. to Begin Trading on NASDAQ Global Market

    Medgenics, Inc. announced today that it has been approved for listing on the NASDAQ Global Market, continuing to trade under the symbol "MDGN." Trading on the NASDAQ Global Market is expected ...

  • 24/7 Wall St.23 days ago

    Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy This Week

    In a Jefferies research report, the top growth stock picks for this week are littered with outstanding biotech companies that could be poised for some big moves.